Tg Therapeutics Stock Price History
| TGTX Stock | USD 32.53 0.97 2.90% |
Below is the normalized historical share price chart for TG Therapeutics extending back to December 14, 1995. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of TG Therapeutics stands at 32.53, as last reported on the 27th of December, with the highest price reaching 33.44 and the lowest price hitting 32.06 during the day.
If you're considering investing in TGTX Stock, it is important to understand the factors that can impact its price. TG Therapeutics appears to be not too volatile, given 3 months investment horizon. TG Therapeutics retains Efficiency (Sharpe Ratio) of 0.14, which indicates the firm had a 0.14% return per unit of price deviation over the last 3 months. By examining TG Therapeutics' technical indicators, you can evaluate if the expected return of 0.61% is justified by implied risk. Please review TG Therapeutics' Mean Deviation of 3.1, risk adjusted performance of 0.1194, and Downside Deviation of 3.83 to confirm if our risk estimates are consistent with your expectations.
At this time, TG Therapeutics' Total Stockholder Equity is fairly stable compared to the past year. Common Stock Shares Outstanding is likely to rise to about 155.9 M in 2024, whereas Common Stock Total Equity is likely to drop slightly above 74.7 K in 2024. . At this time, TG Therapeutics' Price Earnings Ratio is fairly stable compared to the past year. Price Book Value Ratio is likely to rise to 15.86 in 2024, whereas Price To Sales Ratio is likely to drop 9.86 in 2024. TGTX Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 14th of December 1995 | 200 Day MA 21.6519 | 50 Day MA 29.931 | Beta 2.193 |
TGTX |
Sharpe Ratio = 0.1437
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | TGTX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.27 actual daily | 38 62% of assets are more volatile |
Expected Return
| 0.61 actual daily | 12 88% of assets have higher returns |
Risk-Adjusted Return
| 0.14 actual daily | 11 89% of assets perform better |
Based on monthly moving average TG Therapeutics is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of TG Therapeutics by adding it to a well-diversified portfolio.
Price Book 26.3524 | Enterprise Value Ebitda 854.7854 | Price Sales 19.1238 | Shares Float 133.6 M | Wall Street Target Price 40.75 |
TG Therapeutics Stock Price History Chart
There are several ways to analyze TGTX Stock price data. The simplest method is using a basic TGTX candlestick price chart, which shows TG Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | December 2, 2024 | 35.09 |
| Lowest Price | October 7, 2024 | 21.31 |
TG Therapeutics December 27, 2024 Stock Price Synopsis
Various analyses of TG Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell TGTX Stock. It can be used to describe the percentage change in the price of TG Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of TGTX Stock.| TG Therapeutics Price Rate Of Daily Change | 0.97 | |
| TG Therapeutics Price Action Indicator | (0.70) | |
| TG Therapeutics Price Daily Balance Of Power | (0.70) | |
| TG Therapeutics Accumulation Distribution | 64,251 |
TG Therapeutics December 27, 2024 Stock Price Analysis
TGTX Stock Price History Data
The price series of TG Therapeutics for the period between Sat, Sep 28, 2024 and Fri, Dec 27, 2024 has a statistical range of 13.78 with a coefficient of variation of 16.65. The price distribution for the period has arithmetic mean of 28.32. The median price for the last 90 days is 29.54. The company completed stock split (100:5625) on 30th of April 2012.| Open | High | Low | Close | Volume | ||
| 12/27/2024 | 33.26 | 33.44 | 32.06 | 32.53 | 1,556,914 | |
| 12/26/2024 | 32.00 | 33.55 | 31.50 | 33.50 | 1,265,200 | |
| 12/24/2024 | 32.51 | 32.51 | 31.86 | 32.16 | 496,456 | |
| 12/23/2024 | 32.24 | 32.78 | 31.66 | 32.26 | 1,295,165 | |
| 12/20/2024 | 30.60 | 32.63 | 30.50 | 32.20 | 2,793,571 | |
| 12/19/2024 | 31.39 | 31.60 | 30.44 | 30.95 | 1,984,095 | |
| 12/18/2024 | 33.45 | 33.90 | 30.41 | 31.07 | 2,471,657 | |
| 12/17/2024 | 34.30 | 35.03 | 33.32 | 33.57 | 2,864,132 | |
| 12/16/2024 | 32.21 | 35.01 | 32.05 | 34.40 | 3,459,440 | |
| 12/13/2024 | 30.70 | 32.19 | 30.41 | 32.02 | 2,115,275 | |
| 12/12/2024 | 31.80 | 32.29 | 30.46 | 30.69 | 1,679,981 | |
| 12/11/2024 | 32.01 | 32.38 | 31.07 | 31.65 | 1,820,019 | |
| 12/10/2024 | 32.94 | 33.50 | 31.53 | 31.67 | 2,640,626 | |
| 12/09/2024 | 33.71 | 34.10 | 32.72 | 32.84 | 2,180,031 | |
| 12/06/2024 | 33.82 | 34.75 | 33.63 | 33.93 | 1,319,063 | |
| 12/05/2024 | 33.66 | 34.64 | 33.60 | 33.65 | 1,356,439 | |
| 12/04/2024 | 33.37 | 34.33 | 33.30 | 33.88 | 1,762,944 | |
| 12/03/2024 | 35.02 | 35.48 | 33.16 | 33.39 | 2,475,612 | |
| 12/02/2024 | 34.66 | 35.20 | 33.75 | 35.09 | 2,210,571 | |
| 11/29/2024 | 35.19 | 35.78 | 34.71 | 34.80 | 1,262,171 | |
| 11/27/2024 | 34.65 | 35.07 | 33.67 | 35.00 | 1,680,794 | |
| 11/26/2024 | 34.09 | 34.72 | 33.64 | 34.26 | 2,769,948 | |
| 11/25/2024 | 35.89 | 36.84 | 34.51 | 34.61 | 2,955,409 | |
| 11/22/2024 | 34.60 | 35.32 | 33.71 | 35.07 | 2,576,362 | |
| 11/21/2024 | 31.61 | 36.40 | 31.36 | 34.55 | 5,838,364 | |
| 11/20/2024 | 30.45 | 32.00 | 29.91 | 31.15 | 2,226,409 | |
| 11/19/2024 | 29.52 | 30.37 | 29.42 | 30.32 | 2,153,176 | |
| 11/18/2024 | 29.57 | 30.00 | 28.59 | 29.61 | 4,313,364 | |
| 11/15/2024 | 30.70 | 31.24 | 28.91 | 29.54 | 3,275,073 | |
| 11/14/2024 | 34.90 | 36.50 | 30.36 | 30.85 | 8,156,187 | |
| 11/13/2024 | 30.60 | 36.24 | 29.84 | 34.90 | 9,883,193 | |
| 11/12/2024 | 30.46 | 32.48 | 30.41 | 30.91 | 5,492,465 | |
| 11/11/2024 | 29.54 | 30.93 | 29.19 | 30.74 | 5,339,889 | |
| 11/08/2024 | 27.64 | 28.92 | 27.10 | 28.81 | 3,344,481 | |
| 11/07/2024 | 27.30 | 28.41 | 27.05 | 27.90 | 2,838,853 | |
| 11/06/2024 | 27.00 | 27.67 | 26.15 | 27.17 | 4,144,873 | |
| 11/05/2024 | 24.49 | 26.02 | 23.60 | 25.86 | 3,955,284 | |
| 11/04/2024 | 24.39 | 25.05 | 22.92 | 24.36 | 9,598,811 | |
| 11/01/2024 | 25.28 | 26.99 | 25.14 | 26.90 | 5,714,055 | |
| 10/31/2024 | 25.06 | 25.40 | 24.23 | 25.06 | 2,237,603 | |
| 10/30/2024 | 25.66 | 25.78 | 24.78 | 25.13 | 2,391,509 | |
| 10/29/2024 | 26.02 | 26.23 | 24.35 | 25.71 | 4,104,119 | |
| 10/28/2024 | 23.67 | 24.57 | 23.41 | 24.35 | 1,872,872 | |
| 10/25/2024 | 23.26 | 24.31 | 23.22 | 23.36 | 2,132,396 | |
| 10/24/2024 | 23.20 | 23.38 | 22.61 | 23.22 | 1,635,692 | |
| 10/23/2024 | 24.12 | 24.28 | 23.00 | 23.13 | 2,342,768 | |
| 10/22/2024 | 24.27 | 24.66 | 23.66 | 24.25 | 2,282,138 | |
| 10/21/2024 | 23.06 | 24.41 | 22.85 | 24.37 | 2,951,127 | |
| 10/18/2024 | 23.97 | 24.23 | 23.13 | 23.31 | 1,996,252 | |
| 10/17/2024 | 24.40 | 24.69 | 23.84 | 23.94 | 1,703,080 | |
| 10/16/2024 | 24.57 | 24.86 | 24.05 | 24.50 | 2,188,879 | |
| 10/15/2024 | 23.03 | 24.63 | 22.63 | 24.57 | 3,244,669 | |
| 10/14/2024 | 22.07 | 22.88 | 21.82 | 22.83 | 1,871,376 | |
| 10/11/2024 | 21.83 | 22.22 | 21.65 | 22.18 | 2,151,984 | |
| 10/10/2024 | 21.57 | 22.12 | 21.27 | 21.83 | 2,334,482 | |
| 10/09/2024 | 22.06 | 22.58 | 21.61 | 21.90 | 2,409,414 | |
| 10/08/2024 | 21.40 | 22.50 | 21.18 | 21.84 | 2,245,219 | |
| 10/07/2024 | 22.11 | 22.33 | 21.16 | 21.31 | 4,234,404 | |
| 10/04/2024 | 22.50 | 22.75 | 21.64 | 22.23 | 2,258,976 | |
| 10/03/2024 | 22.22 | 22.73 | 22.09 | 22.19 | 1,313,850 | |
| 10/02/2024 | 22.64 | 22.78 | 22.02 | 22.38 | 1,880,145 |
About TG Therapeutics Stock history
TG Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for TGTX is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in TG Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing TG Therapeutics stock prices may prove useful in developing a viable investing in TG Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 148.5 M | 155.9 M | |
| Net Loss | -164.4 M | -172.6 M |
TG Therapeutics Quarterly Net Working Capital |
|
TG Therapeutics Stock Technical Analysis
TG Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Theme Ratings Now
Theme RatingsDetermine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
TG Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for TG Therapeutics' price direction in advance. Along with the technical and fundamental analysis of TGTX Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of TGTX to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1194 | |||
| Jensen Alpha | 0.563 | |||
| Total Risk Alpha | 0.4635 | |||
| Sortino Ratio | 0.1459 | |||
| Treynor Ratio | 0.7015 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for TGTX Stock Analysis
When running TG Therapeutics' price analysis, check to measure TG Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TG Therapeutics is operating at the current time. Most of TG Therapeutics' value examination focuses on studying past and present price action to predict the probability of TG Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TG Therapeutics' price. Additionally, you may evaluate how the addition of TG Therapeutics to your portfolios can decrease your overall portfolio volatility.